查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800190

全球蛋白质体学市场：2025-2030 年预测

Global Proteomics Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

蛋白质体学市场预计将从 2025 年的 367.2 亿美元成长到 2030 年的 575.82 亿美元，复合年增长率为 9.42%。

由于研究蛋白质及其在生物过程中的作用日益重要，蛋白质体学市场正在经历显着增长。蛋白质体学是对生物体蛋白质资料集的全面研究，涵盖蛋白质的结构、功能以及它们在不同细胞和时间点的变化。该领域为理解蛋白质相互作用、定位及其在生物过程中的参与提供了重要见解，对医学和生物学研究的进步至关重要。技术进步和个人化医疗需求的不断增长推动着蛋白质体学市场的发展，但高成本和专业技术人员短缺等挑战可能会阻碍其成长。儘管有这些挑战，但预计该市场仍将扩张，尤其是在医疗基础设施发达、研究资金充足的地区。

关键驱动因素

技术进步

质谱 (MS) 技术（包括液相层析/质谱 (LC/MS)、气相层析/质谱 (GC/MS)、傅立叶变换质谱 (FT-MS) 以及双质谱分析仪（例如基质辅助雷射解吸电离飞行时间/飞行时间(MALDI-TOF/TOF)）的进步是蛋白质体学市场的关键驱动力。

个人化医疗需求日益增长

个人化医疗（根据患者个别情况客製化治疗）日益受到关注，这推动了蛋白质体学的需求。蛋白质体学能够深入了解蛋白质的表达和相互作用，从而开发出标靶治疗，尤其是针对癌症等疾病。随着医疗体系优先考虑精准医疗，旨在识别生物标记和治疗标靶的蛋白质体学研究资金的增加进一步推动了这一需求，从而推动了市场扩张。

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

5. 全球蛋白质体学市场（按技术）

  • 介绍
  • 微阵列
  • 光谱学
  • X射线晶体结构分析
  • 层析法
  • 其他的

6. 全球蛋白质体学市场（按组成部分）

  • 介绍
  • 试剂和套件
  • 耗材
  • 其他的

7. 全球蛋白质体学市场（按试剂）

  • 介绍
  • 微阵列试剂
  • 光谱试剂
  • X射线晶体学试剂
  • 层析法试剂
  • 其他的

8. 全球蛋白质体学市场（按应用）

  • 介绍
  • 蛋白质生物标记的发现
  • 肿瘤转移研究
  • 神经创伤与神经病学
  • 肾臟疾病的诊断
  • 胎儿和母体医学
  • 其他的

9. 全球蛋白质体学市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 印度
    • 其他的

第十章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十一章 公司简介

  • Biognosys AG
  • Creative Proteomics（Division of Creative Dynamics Inc）
  • Proteomics International
  • MRM Proteomics
  • Evotec AG
  • Proteome Factory
  • DC Biosciences
  • AYOXXA Biosystems GmbH
  • VProteomics
  • Thermo Fisher Scientific
  • Agilent Technologies

第十二章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611598

The global proteomics market is expected to grow from USD 36.720 billion in 2025 to USD 57.582 billion in 2030, at a CAGR of 9.42%.

The global proteomics market is experiencing significant growth, driven by the increasing importance of studying proteins and their roles in biological processes. Proteomics, the comprehensive study of an organism's protein dataset, encompasses their structure, functions, and interactions, which vary across cells and over time. This field provides critical insights into protein interactions, localization, and involvement in biological processes, making it essential for advancing medical and biological research. The market is propelled by technological advancements and rising demand for personalized medicine, though challenges such as high costs and a shortage of skilled professionals may hinder growth. Despite these obstacles, the market is poised for expansion, particularly in regions with advanced healthcare infrastructure and strong research funding.

Key Growth Drivers

Technological Advancements

Advancements in technologies such as mass spectrometry (MS), including dual mass analyzers like LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF, are major drivers of the proteomics market. These innovations enable detailed analysis of protein structures, allowing thousands of proteins to be resolved in a single gel. Improvements in protein fractionation techniques and bioinformatics further enhance the ability to process complex proteomic data, driving adoption in research and clinical applications. Increased investments in research and development are also accelerating the development of cutting-edge proteomic tools, supporting market growth.

Rising Demand for Personalized Medicine

The growing focus on personalized medicine, which tailors treatments to individual patient profiles, is boosting demand for proteomics. By providing insights into protein expression and interactions, proteomics enables the development of targeted therapies, particularly for diseases like cancer. This demand is further supported by increased funding for proteomic research, which aims to identify biomarkers and therapeutic targets, driving market expansion as healthcare systems prioritize precision medicine.

Market Segmentation

By Geography

The proteomics market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. North America is expected to hold a significant market share, driven by its rapid adoption of advanced technologies and robust healthcare infrastructure. The region's focus on personalized medicine and substantial investments in research further support market growth. Asia-Pacific is projected to be the fastest-growing region, fueled by rising government funding for proteomics research and increasing interest in precision medicine in countries like China and India, where healthcare systems are expanding rapidly.

Competitive Landscape

Key players, including Proteomics International, Biognosys AG, and Creative Proteomics (a division of Creative Dynamics Inc.), are driving innovation in the proteomics market. These companies focus on developing advanced proteomic technologies and services, enhancing data analysis capabilities, and supporting applications in personalized medicine and biological research, strengthening their market positions.

The global proteomics market is set for robust growth, propelled by advancements in technologies like mass spectrometry and the rising demand for personalized medicine. North America leads due to its advanced infrastructure and research investments, while Asia-Pacific's rapid growth reflects increased funding and healthcare advancements. Despite challenges like high costs and a lack of skilled professionals, the market's trajectory remains positive, driven by the critical role of proteomics in understanding biological processes and developing targeted therapies, supported by ongoing innovation from leading industry players.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Technology

  • Microarrays
  • Spectroscopy
  • X-Ray Crystallography
  • Chromatography
  • Others

By Component

  • Reagents & Kits
  • Consumables
  • Others

By Reagents

  • Microarrays Reagents
  • Spectroscopy Reagents
  • X-Ray Crystallography Reagents
  • Chromatography Reagents
  • Other Reagents

By Application

  • Discovery of Protein Biomarkers
  • Study of Tumor Metastasis
  • Neurotrauma and Neurology
  • Renal Disease Diagnosis
  • Fetal and Maternal Medicine
  • Others

By Geography

  • NorthAmerica
  • United States
  • Canada
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Others
  • Middle East and Africa
  • Israel
  • UAE
  • Saudi Arabia
  • Others
  • Asia Pacific
  • China
  • India
  • Australia
  • South Korea
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL PROTEOMICS MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Microarrays
  • 5.3. Spectroscopy
  • 5.4. X-Ray Crystallography
  • 5.5. Chromatography
  • 5.6. Others

6. GLOBAL PROTEOMICS MARKET BY COMPONENT

  • 6.1. Introduction
  • 6.2. Reagents & Kits
  • 6.3. Consumables
  • 6.4. Others

7. GLOBAL PROTEOMICS MARKET BY REAGENTS

  • 7.1. Introduction
  • 7.2. Microarrays Reagents
  • 7.3. Spectroscopy Reagents
  • 7.4. X-Ray Crystallography Reagents
  • 7.5. Chromatography Reagents
  • 7.6. Other Reagents

8. GLOBAL PROTEOMICS MARKET BY APPLICATION

  • 8.1. Introduction
  • 8.2. Discovery of Protein Biomarkers
  • 8.3. Study of Tumor Metastasis
  • 8.4. Neurotrauma and Neurology
  • 8.5. Renal Disease Diagnosis
  • 8.6. Fetal and Maternal Medicine
  • 8.7. Others

9. GLOBAL PROTEOMICS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. United States
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Others
  • 9.5. Middle East & Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. Japan
    • 9.6.3. South Korea
    • 9.6.4. India
    • 9.6.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Biognosys AG
  • 11.2. Creative Proteomics (Division of Creative Dynamics Inc)
  • 11.3. Proteomics International
  • 11.4. MRM Proteomics
  • 11.5. Evotec AG
  • 11.6. Proteome Factory
  • 11.7. DC Biosciences
  • 11.8. AYOXXA Biosystems GmbH
  • 11.9. VProteomics
  • 11.10. Thermo Fisher Scientific
  • 11.11. Agilent Technologies

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations